Clinical trial suggests Parkinson's drug is safe in humans

A large team of researchers from Denali Therapeutics, working with colleagues from multiple entities in the U.S. and one in Canada, has found that a LRRK2 inhibitor called DNL201 showed no ill effects to volunteers in a clinical ...

Diseases, Conditions, Syndromes

Borrelia bacteria's method of avoiding human immune defenses uncovered

A study conducted at the University of Helsinki under the direction of Docent Taru Meri uncovered a mechanism by which Borrelia bacteria are able to evade human immune defenses. The mechanism identified appears to be particularly ...

page 2 from 40